US EditionTakeda Hosts IBD Nexus Summit, Marking a Decade of Transformative Care for Gastrointestinal Disease Patients
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Takeda hosts IBD Nexus Summit, marking a decade of transformative care for gastrointestinal disease patients
The summit convened IBD experts from the region to support the advancement of Inflammatory Bowel Disease (IBD) patient care Takeda, a global biopharmaceutical leader focused on patient care and one of the key players in the Inflammatory Bowel Disease (IBD) space, hosted the IBD Nexus Summit earlier this year, to raise awareness and enhance knowledge about the disease. The summit brought together renowned healthcare professionals and leading expe…
Ezzat Ali: The Inflammatory Bowel Disease Summit provided a distinguished educational platform. Sami Khalil: We are constantly working to develop treatments to provide a better life for patients. Takeda, a global leader in biopharmaceuticals, organized the Inflammatory Bowel Disease Summit 2025, aiming to enhance patient care by raising awareness and deepening understanding of the disease. The summit witnessed the participation of a group of pro…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
